2.4700
-0.0150
(-0.60%)
As of 1:40:23 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
36,042
36,042
35,680
32,136
13,790
Operating Income
-36,042
-36,042
-35,680
-32,136
-13,790
Net Non Operating Interest Income Expense
3,933
3,933
4,716
1,769
195
Other Income Expense
365
365
1,823
-3,375
-13,669
Pretax Income
-31,744
-31,744
-29,141
-33,742
-27,264
Tax Provision
6
6
16
20
7
Net Income Common Stockholders
-31,750
-31,750
-29,157
-33,762
-27,271
Diluted NI Available to Com Stockholders
-31,750
-31,750
-29,157
-33,762
-27,271
Basic EPS
-0.45
--
-0.42
-0.53
-0.40
Diluted EPS
-0.45
--
-0.42
-0.53
-0.40
Basic Average Shares
69,927.5660
--
69,377.9220
63,534.8750
67,621.4090
Diluted Average Shares
69,927.5660
--
69,377.9220
63,534.8750
67,621.4090
Total Operating Income as Reported
-36,042
-36,042
-35,680
-32,136
-13,790
Total Expenses
36,042
36,042
35,680
32,136
13,790
Net Income from Continuing & Discontinued Operation
-31,750
-31,750
-29,157
-33,762
-27,271
Normalized Income
-32,031.0500
-32,031.0500
-30,560.7100
-31,163.2500
-16,745.8700
Interest Income
4,277
4,277
4,830
1,790
211
Interest Expense
303
303
75
--
--
Net Interest Income
3,933
3,933
4,716
1,769
195
EBIT
-31,441
-31,441
-29,066
-33,742
-27,264
EBITDA
-30,339
-30,339
-27,992
-32,763
-26,488
Reconciled Depreciation
1,102
1,102
1,074
979
776
Net Income from Continuing Operation Net Minority Interest
-31,750
-31,750
-29,157
-33,762
-27,271
Total Unusual Items Excluding Goodwill
365
365
1,823
-3,375
-13,669
Total Unusual Items
365
365
1,823
-3,375
-13,669
Normalized EBITDA
-30,704
-30,704
-29,815
-29,388
-12,819
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
83.9500
83.9500
419.2900
-776.2500
-3,143.8700
12/31/2021 - 3/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EPRX Eupraxia Pharmaceuticals Inc.
3.0500
+0.66%
PYPD PolyPid Ltd.
2.4500
-1.80%
OBIO Orchestra BioMed Holdings, Inc.
2.9200
+12.31%
HLVX HilleVax, Inc.
1.6150
+4.19%
AVTE Aerovate Therapeutics, Inc.
2.6550
+2.91%
ORMP Oramed Pharmaceuticals Inc.
2.1000
-1.41%
EYPT EyePoint Pharmaceuticals, Inc.
5.11
+6.46%
MLLCF Molecular Partners AG
4.2200
0.00%
PLUR Pluri Inc.
3.7401
+0.00%
OCS Oculis Holding AG
16.45
+1.83%